Biosynth, which supplies critical raw materials and services for diagnostics, vaccines and pharmaceuticals, has officially opened its Biosynth Biological Technology site at Lifebay, a technology park in Suzhou, China. Facilities include a bio-laboratory, which, the company said, “significantly enhances capabilities for internal project development initiatives and material supply into the domestic life science market”.

Together with Jinan Shengquan Group, Biosynth Carbosynth is to buy Kexing Biopharmaceutical’s raw material factory in Jinan, China. The facility covers over 30,000 m² over five floors, with a demo workshop and a large warehouse including advanced storage of dangerous material.